constipation while on semaglutide Why Matters GLP-1/GIP-1 Medications Constipation is a common and sometimes underappreciated side effect of GLP-1 and GIP-1 agonists like (Wegovy®) or tirzepatide (Zepbound®). Left untreated, it can lead Severe constipation is never OK

Possible concerns for older adults include: loss of bone or muscle mass (or both) if weight loss is too rapid or not paired with resistance exercise (also called strength training) nutrient deficiencies if their appetite decreases without balancing nutrition, which can worsen existing vitamin B12, vitamin D, and protein deficiencies dehydration, dizziness, or digestive system side effects (such as diarrhea), which may cause new or worsened health problems hypoglycemia (low blood sugar) or hypotension (low blood pressure), which can affect people already taking medications for these conditions increased heart rate or increased blood pressure, which may carry a higher risk in older adults who have heart disease or take heart medications Glucagon-like peptide-1 (GLP-1) receptor agonists are prescription drugs used for weight management and other conditions

For research-protocol design, the practical implication is that dual- and triple-agonist compounds are not interchangeable with stacks of single-agonist components

Avoid eating spicy foods on an empty stomach or immediately before bed, when stomach acid and slower emptying combine to intensify discomfort

People with overweight and obesity run the extra risk of developing other chronic conditions, including diabetes and heart disease

HDAC6-regulated adipokines have been identified as leptin sensitizers, suggesting HDAC6 as a potential therapeutic target for obesity

In a 2017 review, Kruglikov et al